Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis Source: ERJ Open Res 2015; 1: 00044-2015 Year: 2015
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Microevolution of pseudomonas aeruginosa in cystic fibrosis lungs Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Adaptation of prevotella during acute infectious pulmonary exacerbation Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021
Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis Source: Eur Respir J 2011; 37: 553-558 Year: 2011
Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa : Role of inhaled colistin Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Systemic quorum sensing signal molecules are biomarkers for current and future P. aeruginosa infection in cystic fibrosis patients: A longitudinal study Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Quantitative evaluation of CF airways using HRCT, µCT and histology Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014
Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016
Inflammatory biomarkers in urine of cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014